Latest News of VIRI
Enviri Corp (NYSE:NVRI): A Bull Case Theory
By Yahoo! Finance |
2 weeks ago
Enviri Corp (NVRI), formerly Harsco, is a standout in waste management and recycling, offering comprehensive services to global clients. Despite challenges, its strategic initiatives and potential for...
Viridian Therapeutics Discloses 'Exciting' Data From Experimental Thyroid Eye Disease Candidate, Says Data Met High Bars For Efficacy, Safety
By Yahoo! Finance |
3 weeks ago
Viridian Therapeutics released positive data from the THRIVE phase 3 trial of VRDN-001 for thyroid eye disease. Veligrotug showed significant improvements in key disease endpoints, with promising resu...
Viridian Therapeutics Shares Rise on Positive Results of Veligrotug in Thyroid Eye Disease Trial
By MarketWatch |
3 weeks ago
Viridian Therapeutics stock surged before market open following positive phase 3 trial results for their thyroid eye disease treatment. The VRDN-001 treatment showed significant efficacy and safety in...
-
Viridian Therapeutics, Inc. (VRDN) Stock Price, News, Quote & History
By Yahoo! Finance | 2 months agoViridian Therapeutics is a biotech company specializing in treatments for rare diseases. Their pipeline includes VRDN-001 and VRDN-003 for thyroid eye disease, and VRDN-006 for autoimmune diseases. Fo...
-
Viridi Energy signs 20-year deal to supply RNG to Énergi
By Yahoo! Finance | 2 months agoViridi Energy signs a 20-year agreement with Énergir to supply 650,000 gigajoules of RNG annually. The deal aims to help Énergir achieve carbon neutrality by 2050 and increase RNG volumes in their g...
-
Labour rebel suggests she is victim of a 'macho virility test' after suspension over two-child benefit cap - UK politics live
By The Guardian | 2 months agoKeir Starmer faced tough challenges by suspending rebel MPs supporting the two-child benefit limit. MPs including John McDonnell were suspended, sparking criticism and shock. Rebel Zarah Sultana defen...
-
Enviri (NVRI) Flat As Market Sinks: What You Should Know
By Yahoo! Finance | 3 months agoEnviri (NVRI) closed at $8.63, unchanged from the previous day, contrasting with the S&P 500 and Dow losses. NVRI stock gained 2.62% in the last month but underperformed the S&P 500....
-
Are Analysts Bullish on Viridian Therapeutics, Inc. (VRDN) Right Now?
By Yahoo! Finance | 3 months agoA list of top small-cap stocks with high potential was compiled. Viridian Therapeutics, Inc. (NASDAQ:VRDN) stands out with its promising products for autoimmune diseases. Analysts forecast a significa...
-
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Could Be an Important Weapon to Fight Bird Flu H5N1, Says NanoViricides
By Investing News Network | 3 months agoNanoViricides, Inc. discusses the potential of its antiviral drug NV-387 against bird flu H5N1 viruses. Results show its effectiveness in protecting against viral and immune system damage, making it a...
-
Viridis Mining and Minerals Insiders Added AU$3.04m Of Stock To Their Holdings
By Yahoo! Finance | 3 months agoInsiders at Viridis Mining and Minerals Limited (ASX:VMM) have significantly increased their holdings in the past year, indicating optimism about the company. While insider transactions shouldn't be b...